Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala

M. Badruzzaman Khan, Md Nasrul Hoda, Seema Yousuf, Tauheed Ishrat, Muzamil Ahmad, Abdullah Shafique Ahmad, Shareef Haider Alavi, Niloufar Haque, Fakhrul Islam

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Khamira Abresham Hakim Arshad Wala (KAHAW) is an effective and potent cardiac tonic with well-known antioxidant properties. The extensive use of this preparation in Indian system of Unani medicine led us to hypothesize that the pretreatment of this drug to male Wistar rats would prevent cognitive and neurobehavioral impairments. The cognitive impairment was developed by giving single intracerebroventricular injection of 1.5 mg/kg body weight of streptozotocin (STZ) bilaterally. An increased latency and path length was observed in cognitive, i.e. STZ group as compared to sham group and these were restored significantly in STZ group pretreated with KAHAW (700 mg/kg body weight for 15 days). The activity of antioxidant enzymes, viz. glutathione reductase, glutathione S-transferase, glutathione peroxidase, and superoxide dismutase was decreased in STZ group as compared to sham group and pretreatment of STZ group with KAHAW has protected their activities significantly. Moreover, the significantly depleted content of reduced glutathione and significantly elevated level of thiobarbituric acid reactive substances (TBARS) in STZ group were protected significantly with KAHAW. The study concludes that the therapeutic intervention of KAHAW may be used to prevent or to decrease the deterioration of cognitive function and neurobehavioral activities, often associated with the generation of free radicals.

Original languageEnglish (US)
Pages (from-to)68-73
Number of pages6
JournalJournal of Ethnopharmacology
Volume108
Issue number1
DOIs
StatePublished - Nov 3 2006

Fingerprint

Streptozocin
Unani Medicine
Antioxidants
Body Weight
Thiobarbituric Acid Reactive Substances
Glutathione Reductase
Glutathione Peroxidase
Systems Analysis
Glutathione Transferase
Cognition
Superoxide Dismutase
Free Radicals
Glutathione
Cognitive Dysfunction
Wistar Rats
Injections
Enzymes
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala. / Khan, M. Badruzzaman; Hoda, Md Nasrul; Yousuf, Seema; Ishrat, Tauheed; Ahmad, Muzamil; Ahmad, Abdullah Shafique; Alavi, Shareef Haider; Haque, Niloufar; Islam, Fakhrul.

In: Journal of Ethnopharmacology, Vol. 108, No. 1, 03.11.2006, p. 68-73.

Research output: Contribution to journalArticle

Khan, MB, Hoda, MN, Yousuf, S, Ishrat, T, Ahmad, M, Ahmad, AS, Alavi, SH, Haque, N & Islam, F 2006, 'Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala', Journal of Ethnopharmacology, vol. 108, no. 1, pp. 68-73. https://doi.org/10.1016/j.jep.2006.04.012
Khan, M. Badruzzaman ; Hoda, Md Nasrul ; Yousuf, Seema ; Ishrat, Tauheed ; Ahmad, Muzamil ; Ahmad, Abdullah Shafique ; Alavi, Shareef Haider ; Haque, Niloufar ; Islam, Fakhrul. / Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala. In: Journal of Ethnopharmacology. 2006 ; Vol. 108, No. 1. pp. 68-73.
@article{999dd735f6de4edea1d3c736aa50b4bd,
title = "Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala",
abstract = "Khamira Abresham Hakim Arshad Wala (KAHAW) is an effective and potent cardiac tonic with well-known antioxidant properties. The extensive use of this preparation in Indian system of Unani medicine led us to hypothesize that the pretreatment of this drug to male Wistar rats would prevent cognitive and neurobehavioral impairments. The cognitive impairment was developed by giving single intracerebroventricular injection of 1.5 mg/kg body weight of streptozotocin (STZ) bilaterally. An increased latency and path length was observed in cognitive, i.e. STZ group as compared to sham group and these were restored significantly in STZ group pretreated with KAHAW (700 mg/kg body weight for 15 days). The activity of antioxidant enzymes, viz. glutathione reductase, glutathione S-transferase, glutathione peroxidase, and superoxide dismutase was decreased in STZ group as compared to sham group and pretreatment of STZ group with KAHAW has protected their activities significantly. Moreover, the significantly depleted content of reduced glutathione and significantly elevated level of thiobarbituric acid reactive substances (TBARS) in STZ group were protected significantly with KAHAW. The study concludes that the therapeutic intervention of KAHAW may be used to prevent or to decrease the deterioration of cognitive function and neurobehavioral activities, often associated with the generation of free radicals.",
author = "Khan, {M. Badruzzaman} and Hoda, {Md Nasrul} and Seema Yousuf and Tauheed Ishrat and Muzamil Ahmad and Ahmad, {Abdullah Shafique} and Alavi, {Shareef Haider} and Niloufar Haque and Fakhrul Islam",
year = "2006",
month = "11",
day = "3",
doi = "10.1016/j.jep.2006.04.012",
language = "English (US)",
volume = "108",
pages = "68--73",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala

AU - Khan, M. Badruzzaman

AU - Hoda, Md Nasrul

AU - Yousuf, Seema

AU - Ishrat, Tauheed

AU - Ahmad, Muzamil

AU - Ahmad, Abdullah Shafique

AU - Alavi, Shareef Haider

AU - Haque, Niloufar

AU - Islam, Fakhrul

PY - 2006/11/3

Y1 - 2006/11/3

N2 - Khamira Abresham Hakim Arshad Wala (KAHAW) is an effective and potent cardiac tonic with well-known antioxidant properties. The extensive use of this preparation in Indian system of Unani medicine led us to hypothesize that the pretreatment of this drug to male Wistar rats would prevent cognitive and neurobehavioral impairments. The cognitive impairment was developed by giving single intracerebroventricular injection of 1.5 mg/kg body weight of streptozotocin (STZ) bilaterally. An increased latency and path length was observed in cognitive, i.e. STZ group as compared to sham group and these were restored significantly in STZ group pretreated with KAHAW (700 mg/kg body weight for 15 days). The activity of antioxidant enzymes, viz. glutathione reductase, glutathione S-transferase, glutathione peroxidase, and superoxide dismutase was decreased in STZ group as compared to sham group and pretreatment of STZ group with KAHAW has protected their activities significantly. Moreover, the significantly depleted content of reduced glutathione and significantly elevated level of thiobarbituric acid reactive substances (TBARS) in STZ group were protected significantly with KAHAW. The study concludes that the therapeutic intervention of KAHAW may be used to prevent or to decrease the deterioration of cognitive function and neurobehavioral activities, often associated with the generation of free radicals.

AB - Khamira Abresham Hakim Arshad Wala (KAHAW) is an effective and potent cardiac tonic with well-known antioxidant properties. The extensive use of this preparation in Indian system of Unani medicine led us to hypothesize that the pretreatment of this drug to male Wistar rats would prevent cognitive and neurobehavioral impairments. The cognitive impairment was developed by giving single intracerebroventricular injection of 1.5 mg/kg body weight of streptozotocin (STZ) bilaterally. An increased latency and path length was observed in cognitive, i.e. STZ group as compared to sham group and these were restored significantly in STZ group pretreated with KAHAW (700 mg/kg body weight for 15 days). The activity of antioxidant enzymes, viz. glutathione reductase, glutathione S-transferase, glutathione peroxidase, and superoxide dismutase was decreased in STZ group as compared to sham group and pretreatment of STZ group with KAHAW has protected their activities significantly. Moreover, the significantly depleted content of reduced glutathione and significantly elevated level of thiobarbituric acid reactive substances (TBARS) in STZ group were protected significantly with KAHAW. The study concludes that the therapeutic intervention of KAHAW may be used to prevent or to decrease the deterioration of cognitive function and neurobehavioral activities, often associated with the generation of free radicals.

UR - http://www.scopus.com/inward/record.url?scp=33749325518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749325518&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2006.04.012

DO - 10.1016/j.jep.2006.04.012

M3 - Article

VL - 108

SP - 68

EP - 73

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

IS - 1

ER -